Pharmacist review of high-risk haematology outpatients to improve appropriateness of antifungal prophylaxis

International Journal of Clinical Pharmacy

Fecha de publicación: 03 October 2020

DOI: https://doi.org/10.1007/s11096-020-01090-5

Autores: Zainab Reslan, Julian Lindsay, Ian Kerridge , Rochelle Gellatly 

Background: Patients with haematological malignancies are at high risk of invasive fungal infections. However, there is a lack of information about the utilisation of the recommended Australian antifungal prophylaxis guidelines in haematology outpatients.